Search Within

Mark Weiss

  1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Meeting Abstract (22)
  2. Journal Article (8)
  3. Book Section (4)
Groups
  1. Adult Leukemia (34)
  2. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (34)
  3. Center for Hematologic Malignancies (34)
  4. Center for Molecular Imaging and Biotechnology (34)
  5. Department of Medicine (34)
  6. GSK Faculty (34)

More Groups

People
  1. David Scheinberg (34)
  2. Peter Maslak (30)
  3. Joseph Jurcic (15)
  4. Ellin Berman (10)
  5. Nicole Lamanna (9)
  6. Alison Gencarelli (8)

More People

Years
  1. 2010 (1)
  2. 2009 (1)
  3. 2008 (1)
  4. 2006 (1)
  5. 2005 (4)
  6. 2004 (3)

More Years

Publications
  1. Blood (21)
  2. Journal of Clinical Oncology (5)
  3. Leukemia (4)
  4. Cancer: Principles and Practice of Oncology. 5th ed (2)
  5. Cancer: Principles and Practice of Oncology. 6th ed (1)
  6. Cancer: Principles and Practice of Oncology. 7th ed (1)
Publishers
  1. American Society of Hematology (21)
  2. American Society of Clinical Oncology (5)
  3. Nature Publishing Group (4)
  4. Lippincott Williams & Wilkins (2)
  5. Lippincott-Raven (2)

Results (34)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pentostatin and cyclophosphamide with or without rituximab has significant activity in patients with previously treated chronic lymphocytic leukemia and other low grade lymphoid neoplasms
    Meeting Abstract

    Lamanna, N.; Kalaycio, M.; Maslak, P.; Jurcic, J.; Scheinberg, D. A.; Gencarelli, A. N.; Horgan, D.; Weiss, M. A.
    Blood (2004)

    Fulltext@MSK | Save
  • Pentostatin, cydophosphamide, and rituximab (PCR therapy): A new active regimen for previously treated patients with chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Weiss, M. A.; Lamanna, N.; Jurcic, J. G.; Maslak, P. G.; Vonhassel, M.; Horgan, D.; Scheinberg, D. A.; Gencarelli, A. N.
    Blood (2003)

    Fulltext@MSK | Save
  • Reducing standard postremission chemotherapy in acute promyelocytic leukemia (APL) with risk-adapted therapy
    Meeting Abstract

    Mulford, D. A.; Maslak, P. G.; Weiss, M. A.; Scheinberg, D. A.; Jurcic, J. G.
    Blood (2003)

    Fulltext@MSK | Save
  • Sequential therapy with fludarabine, high dose cyclophosphamide, and rituximab induces a high incidence of complete response in patients with chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Lamanna, N.; Weiss, M. A.; Maslak, P. G.; Gencarelli, A. N.; Scheinberg, D. A.; Horgan, D.
    Blood (2003)

    Fulltext@MSK | Save
  • Sequential therapy with fludarabine, high dose cyclophosphamide, and rituximab improves the quality of response in patients with previously untreated chronic lymphocytic leukemia
    Meeting Abstract

    Weiss, M. A.; Lamanna, N.; Gencarelli, A.; Scheinberg, D. A.; Maslak, P. G.; Horgan, D.
    Blood (2002)

    Fulltext@MSK | Save
  • Acute leukemias
    Book Section

    Scheinberg, D. A.; Maslak, P.; Weiss, M.
    In DeVita, V. T. Jr; Hellman, S.; Rosenberg, S. A. (Eds.) Cancer: Principles and Practice of Oncology. 6th ed (2001)

    Fulltext@MSK | Save
  • Pentostatin and cyclophosphamide: A new active regimen for patients with fludarabine refractory CLL
    Meeting Abstract

    Weiss, M. A.; Maslak, P. G.; Jurcic, J. G.; Scheinberg, D. A.; Horgan, D. E.
    Blood (2001)

    Fulltext@MSK | Save
  • Combination pentostatin and cyclophosphamide: Complete responses without severe myelosuppression in previously treated patients with CLL
    Meeting Abstract

    Weiss, M. A.; Maslak, P. G.; Jurcic, J. G.; Scheinberg, D. A.; Horgan, D. E.
    Blood (2000)

    Fulltext@MSK | Save
  • Phase I study of a single high dose of liposomal daunorubicin combined with high dose cytarabine for adult patients with relapsed/refractory acute myelogenous leukemia (AML)
    Meeting Abstract

    Maslak, P.; Weiss, M.; Jurcic, J.; Cathcart, K.; Heaney, M.; Berman, E.; Soignet, S.; Scheinberg, D.; Ward, S.
    Blood (2000)

    Fulltext@MSK | Save
  • Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy
    Journal Article

    Weiss, M. A.; Glenn, M.; Maslak, P.; Rahman, Z.; Noy, A.; Zelenetz, A.; Scheinberg, D. A.; Golde, D. W.
    Leukemia (2000)

    Fulltext@MSK | Save